Regulation of Immune Responses and Chronic Inflammation by Fibroblast-Like Synoviocytes

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2019 Jul 6

PMID 31275325

Citations 84

Authors

Hiroyuki Yoshitomi

Affiliations

Soon will be listed here.

Abstract

Synovial tissue is a membranous non-immune organ lining joint cavities where it supports local immune responses, and functions directly and indirectly in joint destruction due to chronic inflammatory diseases such as rheumatoid arthritis (RA). Fibroblast-like synoviocytes (FLS), the dominant non-immune cells of synovial tissues, mainly contribute to joint destruction via multiple mechanisms. In RA, FLS respond to endogenous ligands of pattern recognition receptors (PRRs) and inflammatory cytokines as non-immune cells. In addition, FLS aid in the activation of immune responses by interacting with immune cells and by supporting ectopic lymphoid-like structure (ELS) formation in synovial tissues. Moreover, FLS directly cause the pathogenicity of RA i.e., joint deformities. Here, we describe new findings and review the mechanisms underlying the regulation of immune reactions by non-immune FLS and their roles in inflammatory diseases such as RA.

Citing Articles

Adipose-derived stem cells attenuate rheumatoid arthritis by restoring CXCR1 synovial lining macrophage barrier.

Wang L, Hao M, Xu Y, Wang Z, Xie H, Zhang B Stem Cell Res Ther. 2025; 16(1):111.

PMID: 40038808 PMC: 11881422. DOI: 10.1186/s13287-025-04144-5.

The D-lactate enigma: exploring the inflammatory influence of D-lactate in cattle.

Burgos R, Manosalva C, Alarcon P, Navarro M, Quiroga J, Moran G Front Vet Sci. 2025; 11:1509399.

PMID: 39744722 PMC: 11688252. DOI: 10.3389/fvets.2024.1509399.

Association Between Dietary Niacin Intake and Rheumatoid Arthritis in American Women: A Study Based on National Health and Nutrition Examination Survey Database.

Hong X, Jiang F Int J Womens Health. 2024; 16:2209-2219.

PMID: 39717391 PMC: 11665156. DOI: 10.2147/IJWH.S482294.

Differential type I and type III interferon expression profiles in rheumatoid and juvenile idiopathic arthritis.

Malik A, Slauenwhite D, McAlpine S, Hanly J, Marshall J, Derfalvi B Front Med (Lausanne). 2024; 11:1466397.

PMID: 39399119 PMC: 11468860. DOI: 10.3389/fmed.2024.1466397.

Methotrexate promotes the release of granulocyte-macrophage colony-stimulating factor from rheumatoid arthritis fibroblast-like synoviocytes via autocrine interleukin-1 signaling.

Bergstrom B, Sellden T, Bollmann M, Svensson M, Hultgard Ekwall A Arthritis Res Ther. 2024; 26(1):178.

PMID: 39394168 PMC: 11468154. DOI: 10.1186/s13075-024-03406-6.

References

Harada S, Yamamura M, Okamoto H, Morita Y, Kawashima M, Aita T . Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1999; 42(7):1508-16. DOI: 10.1002/1529-0131(199907)42:7<1508::AID-ANR26>3.0.CO;2-L. View

Schellekens G, Visser H, de Jong B, van den Hoogen F, Hazes J, Breedveld F . The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000; 43(1):155-63. DOI: 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3. View

Nanki T, Imai T, Nagasaka K, Urasaki Y, Nonomura Y, Taniguchi K . Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis. Arthritis Rheum. 2002; 46(11):2878-83. DOI: 10.1002/art.10622. View

Choy E, Isenberg D, Garrood T, Farrow S, Ioannou Y, Bird H . Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum. 2002; 46(12):3143-50. DOI: 10.1002/art.10623. View

Kyburz D, Rethage J, Seibl R, Lauener R, Gay R, Carson D . Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum. 2003; 48(3):642-50. DOI: 10.1002/art.10848. View

Firestein G . Evolving concepts of rheumatoid arthritis. Nature. 2003; 423(6937):356-61. DOI: 10.1038/nature01661. View

Bradfield P, Amft N, Vernon-Wilson E, Exley A, Parsonage G, Rainger G . Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum. 2003; 48(9):2472-82. DOI: 10.1002/art.11219. View

Proost P, Verpoest S, Van de Borne K, Schutyser E, Struyf S, Put W . Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids. J Leukoc Biol. 2004; 75(5):777-84. DOI: 10.1189/jlb.1003524. View

Ueno A, Yamamura M, Iwahashi M, Okamoto A, Aita T, Ogawa N . The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis. Rheumatol Int. 2004; 25(5):361-7. DOI: 10.1007/s00296-004-0449-x. View

10.

Edwards J, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close D . Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004; 350(25):2572-81. DOI: 10.1056/NEJMoa032534. View

11.

Braun A, Takemura S, Vallejo A, Goronzy J, Weyand C . Lymphotoxin beta-mediated stimulation of synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2004; 50(7):2140-50. DOI: 10.1002/art.20356. View

12.

Brentano F, Schorr O, Gay R, Gay S, Kyburz D . RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum. 2005; 52(9):2656-65. DOI: 10.1002/art.21273. View

13.

Zheng S, Wang J, Stohl W, Kim K, Gray J, Horwitz D . TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J Immunol. 2006; 176(6):3321-9. DOI: 10.4049/jimmunol.176.6.3321. View

14.

Moyron-Quiroz J, Rangel-Moreno J, Hartson L, Kusser K, Tighe M, Klonowski K . Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity. 2006; 25(4):643-54. DOI: 10.1016/j.immuni.2006.08.022. View

15.

Fiedler U, Augustin H . Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 2006; 27(12):552-8. DOI: 10.1016/j.it.2006.10.004. View

16.

Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T . T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med. 2007; 204(1):41-7. PMC: 2118414. DOI: 10.1084/jem.20062259. View

17.

Lee D, Kiener H, Agarwal S, Noss E, Watts G, Chisaka O . Cadherin-11 in synovial lining formation and pathology in arthritis. Science. 2007; 315(5814):1006-10. DOI: 10.1126/science.1137306. View

18.

Naredo E, Collado P, Cruz A, Palop M, Cabero F, Richi P . Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. Arthritis Rheum. 2007; 57(1):116-24. DOI: 10.1002/art.22461. View

19.

. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447(7145):661-78. PMC: 2719288. DOI: 10.1038/nature05911. View

20.

Rengel Y, Ospelt C, Gay S . Proteinases in the joint: clinical relevance of proteinases in joint destruction. Arthritis Res Ther. 2007; 9(5):221. PMC: 2212555. DOI: 10.1186/ar2304. View